Rice Partnership, LLC Abbott Laboratories Transaction History

Rice Partnership, LLC

  • $485 Million
  • Q3 2024

A detailed history of Rice Partnership, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Rice Partnership, LLC holds 17,259 shares of ABT stock, worth $1.97 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
17,259
Previous 17,264 0.03%
Holding current value
$1.97 Million
Previous $1.79 Million 9.7%
% of portfolio
0.41%
Previous 0.4%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$100.07 - $118.13 $500 - $590
-5 Reduced 0.03%
17,259 $1.97 Million
Q2 2024

Aug 01, 2024
SELL
$100.73 - $112.44 $33,845 - $37,779
-336 Reduced 1.91%
17,264 $1.79 Million
Q1 2024

May 15, 2024
SELL
$109.52 - $120.96 $501,820 - $554,238
-4,582 Reduced 20.66%
17,600 $2 Million
Q4 2023

Feb 12, 2024
SELL
$90.19 - $110.4 $510,836 - $625,305
-5,664 Reduced 20.34%
22,182 $2.44 Million
Q3 2023

Nov 13, 2023
SELL
$95.53 - $114.62 $133,550 - $160,238
-1,398 Reduced 4.78%
27,846 $2.7 Million
Q2 2023

Aug 08, 2023
SELL
$100.78 - $112.29 $227,258 - $253,213
-2,255 Reduced 7.16%
29,244 $3.19 Million
Q1 2023

Apr 27, 2023
SELL
$96.86 - $114.01 $111,485 - $131,225
-1,151 Reduced 3.53%
31,499 $3.19 Million
Q4 2022

Jan 26, 2023
SELL
$95.06 - $111.52 $1.93 Million - $2.26 Million
-20,280 Reduced 38.31%
32,650 $0
Q3 2022

Nov 02, 2022
SELL
$96.76 - $112.03 $822,653 - $952,479
-8,502 Reduced 13.84%
52,930 $5.12 Million
Q2 2022

Jul 22, 2022
SELL
$102.07 - $123.37 $1.92 Million - $2.33 Million
-18,850 Reduced 23.48%
61,432 $6.68 Million
Q1 2022

May 13, 2022
BUY
$114.02 - $139.04 $204,665 - $249,576
1,795 Added 2.29%
80,282 $9.5 Million
Q4 2021

Feb 11, 2022
BUY
$115.53 - $141.46 $85,261 - $104,397
738 Added 0.95%
78,487 $11 Million
Q3 2021

Nov 10, 2021
BUY
$116.66 - $129.06 $117,943 - $130,479
1,011 Added 1.32%
77,749 $9.18 Million
Q2 2021

Aug 04, 2021
SELL
$105.79 - $124.53 $464,629 - $546,935
-4,392 Reduced 5.41%
76,738 $8.9 Million
Q1 2021

May 11, 2021
SELL
$108.84 - $128.23 $37,985 - $44,752
-349 Reduced 0.43%
81,130 $9.72 Million
Q4 2020

Feb 09, 2021
BUY
$105.0 - $114.42 $145,530 - $158,586
1,386 Added 1.73%
81,479 $8.92 Million
Q3 2020

Nov 12, 2020
BUY
$91.64 - $111.29 $645,328 - $783,704
7,042 Added 9.64%
80,093 $8.72 Million
Q2 2020

Aug 13, 2020
BUY
$76.57 - $98.0 $5.59 Million - $7.16 Million
73,051 New
73,051 $6.68 Million
Q1 2020

May 11, 2020
SELL
$62.82 - $91.86 $3.85 Million - $5.63 Million
-61,270 Closed
0 $0
Q4 2019

Jan 30, 2020
BUY
$78.51 - $87.4 $307,523 - $342,345
3,917 Added 6.83%
61,270 $5.32 Million
Q3 2019

Nov 07, 2019
BUY
$81.84 - $88.74 $259,105 - $280,950
3,166 Added 5.84%
57,353 $4.8 Million
Q2 2019

Jul 25, 2019
BUY
$72.88 - $85.0 $413,448 - $482,205
5,673 Added 11.69%
54,187 $4.56 Million
Q1 2019

May 06, 2019
BUY
$66.22 - $80.06 $226,803 - $274,205
3,425 Added 7.6%
48,514 $3.88 Million
Q4 2018

Jan 22, 2019
BUY
$65.56 - $74.27 $109,091 - $123,585
1,664 Added 3.83%
45,089 $3.26 Million
Q3 2018

Nov 15, 2018
BUY
$60.81 - $73.36 $101,674 - $122,657
1,672 Added 4.0%
43,425 $3.19 Million
Q2 2018

Aug 21, 2018
BUY
$57.57 - $63.54 $352,040 - $388,547
6,115 Added 17.16%
41,753 $2.55 Million
Q1 2018

May 14, 2018
BUY
$56.27 - $63.62 $57,451 - $64,956
1,021 Added 2.95%
35,638 $2.14 Million
Q4 2017

May 14, 2018
BUY
$53.68 - $57.47 $1.86 Million - $1.99 Million
34,617
34,617 $1.98 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Rice Partnership, LLC Portfolio

Follow Rice Partnership, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Partnership, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Partnership, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email